Figure 1From: Pressure for drug development in lysosomal storage disorders – a quantitative analysis thirty years beyond the US orphan drug actNumber of orphan drug designations (open bars) and FDA approvals (full bars) for compounds intended to treat lysosomal storage diseases by year.Back to article page